Mavyret (Generic Glecaprevir-Pibrentasvir): Complete Medication Guide
Key Takeaways
Mavyret is a direct-acting antiviral (DAA) combination therapy that cures hepatitis C in 8-12 weeks for most patients.
It works by blocking viral proteins that hepatitis C needs to replicate and spread in the body.
Common side effects are usually mild, with fatigue and headache being the most frequently reported.
Mavyret can interact with certain medications, so always discuss your current drug list with your doctor.
Generic glecaprevir-pibrentasvir is cost-effective alternative to brand-name drugs and offers the same cure rates as the brand version.
Mavyret Overview
Mavyret is a combination medication containing two active ingredients: glecaprevir and pibrentasvir. It belongs to a class of drugs called direct-acting antivirals (DAAs), which target specific hepatitis C virus proteins to stop the virus from multiplying in your body. Hepatitis C is a serious liver infection that can lead to scarring (cirrhosis), liver failure, and liver cancer if left untreated.
Glecaprevir is a protease inhibitor that blocks an enzyme the virus needs to replicate, while pibrentasvir is an NS5A inhibitor that prevents viral RNA from being packaged into new virus particles. Together, these two medicines work synergistically to achieve cure rates exceeding 95% across all hepatitis C genotypes (the different genetic versions of the virus). The generic version of Mavyret contains the exact same active ingredients as the brand-name drug and offers same effectiveness at a lower cost.
Treatment with Mavyret typically lasts 8-12 weeks, depending on your specific genotype, whether you've been treated before, and whether you have cirrhosis. Most patients achieve a sustained virologic response (SVR)—meaning the virus is undetectable and cured—after completing the full course of therapy.
This information is educational and does not replace advice from your healthcare provider.
Side Effects
Mavyret is generally well tolerated, with most patients experiencing mild or no side effects. Serious adverse effects are uncommon, but you should know what to watch for.
Common Side Effects
Fatigue: Feeling unusually tired or lacking energy is the most frequently reported side effect. It usually improves as your treatment progresses.
Headache: Mild to moderate headaches occur in some patients. Over-the-counter pain relievers may help.
Nausea: Mild stomach upset or queasiness is possible. Taking the medication with food may reduce this symptom.
Diarrhea: Loose stools or digestive changes can occur but tend to be mild and temporary.
Insomnia or Sleep Disturbances: Some patients report difficulty sleeping or feeling restless, especially early in treatment.
Serious Side Effects
Liver Function Changes: While rare, your liver enzymes may temporarily increase. Your doctor monitors these with regular blood tests.
Reactivation of Hepatitis B: If you have both hepatitis B and C, Mavyret may cause hepatitis B to reactivate. Your doctor will screen for this before treatment.
Severe Allergic Reaction: Rash, swelling of the face or throat, or difficulty breathing requires immediate medical attention.
Severe Fatigue or Mental Changes: Extreme tiredness, depression, or difficulty concentrating beyond normal side effects warrant medical evaluation.
When to Seek Medical Attention
Contact your healthcare provider if you experience persistent or worsening fatigue, dark urine, yellowing of the skin or eyes, abdominal pain, or severe headache. While most side effects resolve on their own, your doctor needs to know if symptoms are affecting your quality of life or if new symptoms develop during treatment.
If you experience difficulty breathing, severe swelling, or signs of an allergic reaction, seek emergency care immediately.
Dosage
Dose Level or Form |
Dose |
Key Detail |
Standard Dose (Most Patients) |
300 mg glecaprevir / 120 mg pibrentasvir once daily |
Take with food; standard treatment is 8 weeks |
Treatment Duration (Genotypes 1-6) |
8 weeks |
For treatment-naive patients without cirrhosis |
Treatment Duration (With Cirrhosis) |
12 weeks |
For patients with compensated cirrhosis or treatment experience |
Renal Impairment |
300 mg / 120 mg once daily |
No dose adjustment needed for kidney disease |
Hepatic Impairment |
Do not use |
Mavyret is contraindicated in severe liver disease (Child-Pugh C) |
Important: Do not stop taking Mavyret without talking to your doctor, even if you feel better. Stopping early reduces your chance of cure. If you miss a dose, take it as soon as you remember on the same day. If you miss an entire day, skip the missed dose and resume your normal schedule. Do not double up on doses.
Drug Interactions
Mavyret can interact with other medications, supplements, and even some foods. These interactions may reduce Mavyret's effectiveness or increase your risk of side effects. Always provide your doctor with a complete list of all medications, vitamins, and supplements you take.
Strong CYP3A Inducers
Medications like rifampicin, carbamazepine, and St. John's Wort significantly reduce glecaprevir and pibrentasvir levels in your blood, making Mavyret less effective. If possible, avoid these drugs or use alternative treatments during Mavyret therapy.
HIV Protease Inhibitors and Ritonavir
Certain HIV medications (especially when boosted with ritonavir) can increase Mavyret blood levels, raising the risk of toxicity. Your doctor may need to adjust doses or monitor you more closely if you take both.
Atazanavir and Darunavir
These HIV medications can increase glecaprevir concentrations significantly. Use only if benefits outweigh risks, and have your doctor adjust your regimen and monitor liver function closely.
P-gp Inhibitors (Amiodarone, Verapamil, Dronedarone)
These heart medications may increase Mavyret levels and could raise toxicity risk. Discuss alternatives with your cardiologist or have your doctor adjust monitoring protocols.
Certain Statins (Pravastatin, Rosuvastatin)
Pravastatin and rosuvastatin are safer choices with Mavyret, but other statins like simvastatin or atorvastatin may reach dangerously high levels. Your doctor may switch you to a safer statin or adjust doses.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
High Cure Rate: Over 95% of patients achieve sustained virologic response, effectively curing hepatitis C.
Short Treatment Duration: Most patients complete therapy in 8 weeks, compared to much longer treatment courses in the past.
Once-Daily Dosing: Simple regimen with only one pill per day makes adherence easier.
Pangenotypic Coverage: Effective against all six major hepatitis C genotypes without the need for genotype-specific regimens.
Generic Availability: The generic version provides the same effectiveness at a lower cost compared to the brand-name drug.
Cons
Drug Interactions: Significant interactions with certain medications require careful medication review before starting.
Hepatitis B Risk: Patients with hepatitis B face reactivation risk and need close monitoring.
Not for Severe Liver Disease: Contraindicated in patients with Child-Pugh Class C cirrhosis, limiting treatment options for those with advanced disease.
Upfront Cost Considerations: While generics are cheaper, even generic pricing can be high without insurance coverage.
Limited Pregnancy Data: Lack of robust safety data in pregnancy may make treatment timing a consideration for women planning conception.
Frequently Asked Questions
Get answers to common questions about Mavyret.
Yes, generic glecaprevir-pibrentasvir contains the exact same active ingredients and achieves the same cure rates (>95%) as the brand-name Mavyret. The FDA requires generic medications to meet the same strict standards for safety and effectiveness. the differences between generic and brand-name drugs can help you make informed decisions about your treatment options.
Most patients achieve cure in 8-12 weeks of taking Mavyret once daily. For treatment-naive patients without cirrhosis, 8 weeks is standard. Patients with cirrhosis or prior treatment experience typically need 12 weeks. Your doctor will confirm your specific treatment duration based on your genotype and liver status.
If you miss a dose, take it the same day as soon as you remember. If you miss an entire day, skip that dose and take your next dose the following day at your regular time. Never double up on doses to make up for a missed one. Consistent daily dosing is important for maintaining adequate drug levels to cure the virus.
Patients with both hepatitis B and C can take Mavyret, but require special monitoring. Mavyret can cause hepatitis B reactivation, which may lead to severe liver inflammation. Your doctor must test you for hepatitis B before starting treatment and may recommend starting hepatitis B antiviral therapy before or alongside Mavyret to prevent reactivation.
Avoid St. John's Wort, a herbal supplement used for depression, as it significantly reduces Mavyret effectiveness. Take Mavyret with food to improve absorption and reduce nausea. Some grapefruit and grapefruit juice may increase drug levels, so discuss citrus fruit intake with your pharmacist. Always inform your doctor about supplements before starting treatment.
The Bottom Line
Mavyret (generic glecaprevir-pibrentasvir) offers hepatitis C patients a highly effective, short-course treatment with cure rates exceeding 95%. The once-daily pill regimen is convenient, and the generic version provides the same proven results at lower cost than the brand name. While drug interactions and hepatitis B reactivation risk require careful medical oversight, most patients tolerate the medication well with minimal side effects. Treatment typically lasts 8-12 weeks, and many people experience life-changing health improvements after curing their hepatitis C infection. If you're considering Mavyret as a treatment option, Doctronic can help you understand your options and connect you with a healthcare provider for personalized guidance.
Ready to take control of your health? Get started with Doctronic today—where you can access free AI consultations and speak with physicians via video or text visits in as little as 4 minutes, 24/7.
